S M S Scientific Products Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 16-11-2024
- Paid Up Capital ₹ 0.20 M
as on 16-11-2024
- Company Age 43 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.65 Cr
as on 16-11-2024
- Revenue -32.61%
(FY 2023)
- Profit -24.32%
(FY 2023)
- Ebitda -32.97%
(FY 2023)
- Net Worth 30.33%
(FY 2023)
- Total Assets 47.91%
(FY 2023)
About S M S Scientific Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹4.65 Cr.
Jayanti Ahuja and Haresh Ahuja serve as directors at the Company.
- CIN/LLPIN
U33100MH1981PTC024484
- Company No.
024484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at S M S Scientific Products?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haresh Ahuja  | Managing Director | 06-Apr-1993 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayanti Ahuja | Director | 01-Apr-2000 | Current |
Financial Performance of S M S Scientific Products.
S M S Scientific Products Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.61% decrease. The company also saw a substantial fall in profitability, with a 24.32% decrease in profit. The company's net worth Soared by an impressive increase of 30.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S M S Scientific Products?
In 2019, S M S Scientific Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 May 2020 | ₹1.00 Cr | Open |
The Saraswat Cooperative Bank Ltd Creation Date: 15 Jul 2002 | ₹1.00 Cr | Open |
Others Creation Date: 26 May 1994 | ₹2.45 Cr | Open |
How Many Employees Work at S M S Scientific Products?
S M S Scientific Products has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S M S Scientific Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S M S Scientific Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
